Showing results (241-250 of 284) with videos related to
Sort By:
Pageof 29
Head & Neck|December 24, 1997
Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomographyV J Lowe, F R Dunphy, M Varvares, et al.The American Journal of the Medical Sciences|April 4, 2000
Rising levels of cardiovascular mortality in Mississippi, 1979-1995D W Jones, C T Sempos, T J Thom, et al.Journal of the National Medical Association|June 1, 1987
Coronary artery bypass grafting in a predominately black group of patientsR L Peniston, N Miles, R C Lowery, et al.Cancer Nursing|August 2, 2007
What women wish they knew before prophylactic mastectomySharon J Rolnick, Andrea Altschuler, Larissa Nekhlyudov, et al.Journal of the National Cancer Institute|December 4, 2015
Tamoxifen and Antidepressant Drug Interaction in a Cohort of 16,887 Breast Cancer SurvivorsReina Haque, Jiaxiao Shi, Joanne E Schottinger, et al.Archives of Disease in Childhood|April 1, 1975
Urinary tract in schoolgirls with covert bacteriuriaM S McLachlan, S T Meller, E R Jones, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Prospective investigation of positron emission tomography in lung nodulesV J Lowe, J W Fletcher, L Gobar, et al.Breast Cancer Research : BCR|November 20, 2009
Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community settingLaurel A Habel, Ninah S Achacoso, Reina Haque, et al.Breast Cancer Research and Treatment|March 23, 2016
Effectiveness of bisphosphonate use and risk of contralateral breast cancer and recurrence in women with early-stage breast cancer treated with tamoxifenMarilyn L Kwan, Jiaxiao M Shi, Laurel A Habel, et al.International Journal of Radiation Oncology, Biology, Physics|May 29, 2009
A pilot trial of serial 18F-fluorodeoxyglucose positron emission tomography in patients with medically inoperable stage I non-small-cell lung cancer treated with hypofractionated stereotactic body radiotherapyMark A Henderson, David J Hoopes, James W Fletcher, et al.Pageof 29